NextCell Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022
Cash & Equivalents	26.03	38.72	46.79	50.03	97.12
Cash & Short-Term Investments	26.03	38.72	46.79	50.03	97.12
Cash Growth	-32.77%	-17.24%	-6.47%	-48.49%	-30.22%
Accounts Receivable	3.06	3	1.67	2.35	1.78
Other Receivables	2.4	1.98	1.45	1.24	0.93
Receivables	5.47	4.98	3.12	3.58	2.71
Inventory	0.33	0.55	0.55	0.79	0.77
Prepaid Expenses	9.57	10.15	10.17	12.87	6.16
Other Current Assets	-	-	0.05	0	-
Total Current Assets	41.4	54.4	60.67	67.27	106.75
Property, Plant & Equipment	14.27	14.33	12.66	13.55	9.9
Long-Term Investments	7.2	6.87	6.92	6.87	6.87
Other Long-Term Assets	1.05	1.14	1.03	1.13	1.13
Total Assets	63.92	76.73	81.29	88.83	124.66
Accounts Payable	3.34	2.69	6.16	0.89	1.92
Accrued Expenses	3.38	2.25	2.49	7.65	4.16
Current Unearned Revenue	-	-	0.25	0.2	-
Other Current Liabilities	1.31	0.49	0.98	1.35	0.85
Total Current Liabilities	8.03	5.43	9.87	10.08	6.93
Long-Term Unearned Revenue	5.29	4.92	3.82	3.02	2.18
Other Long-Term Liabilities	0	-0	-0	-0	-
Total Liabilities	13.32	10.34	13.69	13.1	9.12
Common Stock	22.84	22.84	14.98	7.05	7.05
Additional Paid-In Capital	248.41	248.41	222.33	196.43	196.43
Retained Earnings	-220.64	-204.85	-169.71	-127.75	-87.94
Shareholders' Equity	50.6	66.39	67.6	75.73	115.54
Total Liabilities & Equity	63.92	76.73	81.29	88.83	124.66
Net Cash (Debt)	26.03	38.72	46.79	50.03	97.12
Net Cash Growth	-32.77%	-17.24%	-6.47%	-48.49%	-30.22%
Net Cash Per Share	-	0.51	1.15	1.46	2.82
Filing Date Shares Outstanding	111.39	111.39	73.09	34.38	34.38
Total Common Shares Outstanding	111.39	111.39	73.09	34.38	34.38
Working Capital	33.37	48.97	50.8	57.19	99.82
Book Value Per Share	0.45	0.60	0.92	2.20	3.36
Tangible Book Value	50.6	66.39	67.6	75.73	115.54
Tangible Book Value Per Share	0.45	0.60	0.92	2.20	3.36
Machinery	-	-	16.04	5.22	5.15
Construction In Progress	-	-	-	11.59	7.56

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.